MULTIPLEXABLE CRISPR-CAS9-BASED VIRUS DETECTION METHOD

The present invention belongs to the field of biomedicine and viral diagnosis. In particular, the invention relates to a method for in vitro virus detection and/or in vitro specific viral sequence detection, including without limitation to, SARS-CoV-2 detection, based on the use of a CRISPR-Cas9 sys...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	RUIZ GONZÁLEZ, Raúl, MONTAGUD MARTÍNEZ, Roser, RODRIGO TÁRREGA, Guillermo, MÁRQUEZ COSTA, Rosa, HERAS HERNÁNDEZ, María
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR COMPOSITIONS THEREOF CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES CULTURE MEDIA ENZYMOLOGY MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PROCESSES OF PREPARING SUCH COMPOSITIONS PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention belongs to the field of biomedicine and viral diagnosis. In particular, the invention relates to a method for in vitro virus detection and/or in vitro specific viral sequence detection, including without limitation to, SARS-CoV-2 detection, based on the use of a CRISPR-Cas9 system. La présente invention a trait au domaine de la biomédecine et du diagnostic viral. En particulier, l'invention concerne un procédé de détection de virus in vitro et/ou de détection de séquence virale spécifique in vitro, comprenant, entre autres, la détection du SARS-CoV-2, reposant sur l'utilisation d'un système CRISPR-Cas9.